MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd).

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 1.57mg modified-release tablets (Boehringer Ingelheim Ltd).

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 2.1mg modified-release tablets (Boehringer Ingelheim Ltd).

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 1.05mg modified-release tablets (Boehringer Ingelheim Ltd).

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 0.52mg modified-release tablets (Boehringer Ingelheim Ltd).

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 0.26mg modified-release tablets (Boehringer Ingelheim Ltd).

Stability Notes

Store in original packaging to protect from moisture.

Provenance

This compatibility recommendation is derived from Emend 125mg capsules (Merck Sharp & Dohme (UK) Ltd).

Stability Notes

Protect from light. Store in airtight containers.

Provenance

This compatibility recommendation is derived from Phenergan 10mg tablets (Sanofi).

Stability Notes

Protect from light. Store in airtight containers.

Provenance

This compatibility recommendation is derived from Phenergan 25mg tablets (Sanofi).

Stability Notes

Store in tight, light-resistant containers.

Provenance

This compatibility recommendation is derived from Aldactone 25mg tablets (Pfizer Ltd).

Stability Notes

Protect from light. Protect from moisture. Store in an airtight container. Unsuitable due to administration - chewable tablet.

Provenance

Compatibility recommendation derived from Montelukast 4mg chewable tablets sugar free (Accord Healthcare Ltd).

Stability Notes

Protect from light.

Provenance

Compatibility recommendation derived from Olmetec 10mg tablets (Daiichi Sankyo UK Ltd).

Stability Notes

Protect from light.

Provenance

Compatibility recommendation derived from Olmetec 20mg tablets (Daiichi Sankyo UK Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.